FERRANTE, EMANUELE
FERRANTE, EMANUELE
Universita' degli Studi di MILANO
Clinical picture of early infancy PTH resistance syndromes: is it time to improve diagnostic criteria?
2026 G. Del Sindaco, J. Berkenou, A. Pagnano, C. Audrain, E. Ferrante, A. Rothenbuhler, A. Linglart, G. Mantovani
Progression of bilateral adrenal incidentalomas: a monocentric cohort study
2026 A. Mangone, I. Pes, S. Frigerio, R. Renda, E. Ferrante, E. Peverelli, G. Mantovani, S. Palmieri
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study
2026 A. Mangone, B. Altieri, E. Ferrante, I. Bancos, M. Luconi, B. Ziółkowska, A. Barač Nekić, R. Libe, F. Ceccato, J.F. H Pittaway, M. Laganà, G. Di Dalmazi, E. Peverelli, O. Kimpel, B. Bahrani Fard, L. Canu, A. Kotecka-Blicharz, D. Kastelan, L. Bouys, I. Tizianel, G. Bennett, M. P Schauer, Y. S Elhassan, M. Detomas, L. Zanatta, M. Sadiq, G. Mantovani, C.L. Ronchi
Exploring the Role of Skull Base Anatomy in Surgical Approach Selection and Endocrinological Outcomes in Craniopharyngiomas
2026 A. Tozzi, G. Fiore, E. Sala, G.A. Bertani, S. Borsa, I. Carnicelli, E. Ferrante, G. Platania, G. Mantovani, M. Locatelli
Persistent remission after steroidogenesis inhibitor discontinuation in Cushing disease: a case series
2026 A. Mangone, E. Sala, G. Carosi, G.D. Sindaco, R. Mungari, A. Cremaschi, I. Petria, G. Noschese, V. Lotito, G. Mantovani, E. Ferrante
Neuropsychological profile in acromegaly: a single center cross sectional analysis and preliminary prospective long-term study
2026 G. Abete Fornara, A. Mangone, V. Lotito, G. Del Sindaco, A. Cremaschi, G. Carosi, R. Mungari, E. Ferrante, G.A. Bertani, G. Fiore, M. Locatelli, E. Sala, G. Mantovani
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas
2026 E. Esposito, E. Nozza, A.M. Barbieri, L. Bosoni, P. A Foster, V. Chortis, R. Catalano, S. Di Bari, L. Beevors, G. Di Dalmazi, L. Landwehr, C. Hantel, A. Abate, M. Tamburello, A. Mangone, S. Palmieri, E. Ferrante, G. Mantovani, E. Peverelli, C. L Ronchi
IGF2R: a new player in the IGF2 loop sustaining adrenocortical carcinogenesis
2026 E. Nozza, E. Esposito, S. Di Bari, R. Catalano, G. Di Muro, A.M. Barbieri, E. Cassinotti, S. Palmieri, A. Mangone, V. Morelli, M. Tamburello, C. Hantel, L. Landwehr, G. Di Dalmazi, E. Ferrante, G. Mantovani, E. Peverelli
Challenges and unmet needs in diagnosing polyuria-polydipsia syndrome: National survey by the Italian Society of Endocrinology
2025 A.M. Berton, E. Ferrante, P. Razzore
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A.G. Lania, E. Ferrante, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani
Sphingosine kinase 1 inhibitor safingol as a new possible therapeutic strategy for adrenocortical carcinoma
2024 E. Nozza, R. Catalano, E. Esposito, S. Palmieri, B. Altieri, L. Landwehr, H. Constanze, S. Sigala, E. Ferrante, G. Mantovani, E. Peverelli
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes
2024 A. Cremaschi, G. DEL SINDACO, A. Pagnano, A. Dolci, J. Berkenou, A. Rothenbuhler, A. Contarino, E. Ferrante, M. Arosio, E. Giannetta, A. Linglart, G. Mantovani
Macro-FSH is a rare cause of inappropriately high FSH concentrations
2024 B. Mantovani, R. Indirli, V. Lanzi, I. Petria, M. Arosio, G. Mantovani, E. Somigliana, M. Vidali, F. Ceriotti, E. Ferrante
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth
2023 E. Nozza, R. Catalano, E. Esposito, A.M. Barbieri, G. Marra, D. Treppiedi, G. Di Muro, F. Mangili, H. Constanze, S. Sigala, S. Palmieri, S. Frigerio, E. Ferrante, M. Arosio, G. Mantovani, E. Peverelli
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
2023 G. Di Muro, F. Mangili, E. Esposito, A.M. Barbieri, R. Catalano, D. Treppiedi, G. Marra, E. Nozza, A.G.A. Lania, E. Ferrante, M. Locatelli, M. Arosio, E. Peverelli, G. Mantovani
Predicting tumor consistency and extent of resection in non-functioning pituitary tumors
2023 G. Fiore, G.A. Bertani, G. Conte, E. Ferrante, L. Tariciotti, E. Kuhn, L. Runza, M. Pluderi, S. Borsa, M. Caroli, E. Sala, G. Platania, K. Kremenova, S. Ferrero, F.M. Triulzi, G. Mantovani, M. Locatelli
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients
2022 R. Indirli, A. Bandera, L. Valenti, F. Ceriotti, A. Di Modugno, M. Tettamanti, R. Gualtierotti, F. Peyvandi, N. Montano, F. Blasi, G. Costantino, V. Resi, E. Orsi, M. Arosio, G. Mantovani, E. Ferrante
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant
2021 D. Treppiedi, A.M. Barbieri, G. Di Muro, G. Marra, F. Mangili, R. Catalano, E. Esposito, E. Ferrante, A.L. Serban, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, E. Peverelli, G. Mantovani